AI Summary
Thinking
Thinking
We reviewed 3 live results for nih sbir consultant and narrowed them down to the 3 options that look most worth comparing first.
The options are NIH Grant Consultant, CASIO FC-200V Financial Consultant and Comprehensive SBIR Consulting Services.
Source: ReofTech
Description
ReofTech provides specialized NIH grant consulting, proposal development, and grant writing services designed to assist researchers, universities, and biotech startups in securing competitive federal funding. The service covers strategic funding opportunity identification across mechanisms like R01, R21, and SBIR/STTR, concept planning, full proposal drafting, scientific editing, formatting compliance, and submission support on Grants.gov or eRA Commons. Additionally, the team provides score-based peer review evaluations, revision guidance, and comprehensive resubmission support tailored to NIH review criteria.
Best for
Researchers, Biotech startups, Applying for NIH R01, R21, or SBIR/STTR grants and NIH grant resubmission and proposal revision
Rate this product
Source: Mmarket.com.hk
Description
CASIO FC-200V 是一款專業財務計算機（Financial Consultant），配備 4 行點陣顯示屏（10+2 位數）與太陽能及鈕扣電池雙電源供電。機身具備直捷模式鍵，支援單利、複利、現金流投資評估、攤銷、利率轉換、折舊、債券計算及損益平衡點等多元財務分析與統計運算功能，並隨附滑蓋保護硬殼。
Best for
財務金融從業人員, 商管學院學生, 財務與投資分析計算 and 課堂教學與學習
Rate this product
Source: REOFTech
Description
Comprehensive SBIR Consulting Services by REOFTech assists startups, researchers, and innovators in securing competitive Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) federal funding. The service provides end-to-end guidance across major federal agencies like NIH, DoD, DOE, and NSF, spanning opportunity identification, proposal writing, agency-specific funding strategy alignment, STTR partnership consulting, Phase II commercialization plan development, compliance reviews, and post-award reporting assistance.
Best for
Startups, Researchers, Applying for SBIR and STTR federal grants and Developing Phase II commercialization plans
Rate this product
| Compare | #1NIH Grant Consultant | #2CASIO FC-200V Financial Consultant | #3Comprehensive SBIR Consulting Services |
|---|---|---|---|
| Source | ReofTech | Mmarket.com.hk | REOFTech |
| Description | ReofTech provides specialized NIH grant consulting, proposal development, and grant writing services designed to assist researchers, universities, and biotech startups in securing competitive federal funding. The service covers strategic funding opportunity identification across mechanisms like R01, R21, and SBIR/STTR, concept planning, full proposal drafting, scientific editing, formatting compliance, and submission support on Grants.gov or eRA Commons. Additionally, the team provides score-based peer review evaluations, revision guidance, and comprehensive resubmission support tailored to NIH review criteria. | CASIO FC-200V 是一款專業財務計算機（Financial Consultant），配備 4 行點陣顯示屏（10+2 位數）與太陽能及鈕扣電池雙電源供電。機身具備直捷模式鍵，支援單利、複利、現金流投資評估、攤銷、利率轉換、折舊、債券計算及損益平衡點等多元財務分析與統計運算功能，並隨附滑蓋保護硬殼。 | Comprehensive SBIR Consulting Services by REOFTech assists startups, researchers, and innovators in securing competitive Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) federal funding. The service provides end-to-end guidance across major federal agencies like NIH, DoD, DOE, and NSF, spanning opportunity identification, proposal writing, agency-specific funding strategy alignment, STTR partnership consulting, Phase II commercialization plan development, compliance reviews, and post-award reporting assistance. |
| Best for | Researchers, Biotech startups, Applying for NIH R01, R21, or SBIR/STTR grants and NIH grant resubmission and proposal revision | 財務金融從業人員, 商管學院學生, 財務與投資分析計算 and 課堂教學與學習 | Startups, Researchers, Applying for SBIR and STTR federal grants and Developing Phase II commercialization plans |
| Action | ReofTech | Mmarket.com.hk | REOFTech |
| Rate this product |
"NIH Grant Consultant from ReofTech."
Note: TopFind AI compiles financial product information for general comparison purposes only. It does not constitute financial advice.